Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
McKesson
Teva
Cipla
AstraZeneca
Julphar
Moodys
Daiichi Sankyo
Deloitte

Generated: September 23, 2018

DrugPatentWatch Database Preview

DYANAVEL XR Drug Profile

« Back to Dashboard

Which patents cover Dyanavel Xr, and when can generic versions of Dyanavel Xr launch?

Dyanavel Xr is a drug marketed by Tris Pharma Inc and is included in one NDA. There are five patents protecting this drug.

The generic ingredient in DYANAVEL XR is amphetamine. There are fifty-four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the amphetamine profile page.

Drug patent expirations by year for DYANAVEL XR
Pharmacology for DYANAVEL XR
Synonyms for DYANAVEL XR
.alpha.-Methylbenzeneethanamine
.alpha.-Methylbenzeneethaneamine
.alpha.-Methylphenethylamine
.alpha.-Methylphenethylamine, d-form
.alpha.-Methylphenylethylamine
.beta.-Aminopropylbenzene
.beta.-Phenylisopropylamin
.beta.-Phenylisopropylamine
(.+/-.)-.alpha.-Methylphenethylamine
(.+/-.)-.alpha.-Methylphenylethylamine
(.+/-.)-.beta.-Phenylisopropylamine
(.+/-.)-Benzedrine
(.+/-.)-Desoxynorephedrine
(+-)-alpha-Methylbenzeneethanamine
(+-)-alpha-Methylphenethylamine
(+-)-alpha-Methylphenylethylamine
(+-)-Benzedrine
(+)-.alpha.-Methylphenethylamine
(+)-.alpha.-Methylphenylethylamine
(+/-)-1-Phenyl-2-aminopropane
(+/-)-Amphetamine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
(+/-)-Amphetamine solution, 100 mug/mL in methanol, ampule of 1 mL, certified reference material
(Phenylisopropyl)amine
(plusmn)-amphetamine
(S)-.alpha.-Phenylethylamine
(S)-(+)-.beta.-Phenylisopropylamine
[1-(3-Methoxyphenyl)-2-propyl]amine
1-benzylethylamine
1-Methyl-2-phenylethylamine
1-Phenyl-2-amino-propan
1-Phenyl-2-amino-propan [German]
1-Phenyl-2-aminopropane
1-Phenyl-2-aminopropane (VAN)
1-Phenyl-2-propanamine
1-Phenyl-2-propylamine
1-phenylpropan-2-amine
17108-96-2
2-Amino-1-phenylpropane
3-Phenyl-2-propylamine
3-phenylpropan-2-amine
300-62-9
3797-EP2275420A1
3797-EP2295439A1
3797-EP2298734A2
3797-EP2298742A1
3797-EP2298779A1
3797-EP2305219A1
3797-EP2305648A1
3797-EP2305656A1
3797-EP2308867A2
3797-EP2308870A2
3797-EP2311801A1
3797-EP2311802A1
3797-EP2311803A1
3797-EP2314571A2
3797-EP2371814A1
60-13-9 (sulfate (2:1))
60-15-1
96332-84-2
AC1L1EYQ
AC1Q5065
Actedron
Adderal
Adderall
Adderall XR
Adipan
Adzenys ER
AI3-02438
AKOS022196414
Allodene
alpha-methyl phenethylamine
ALPHA-METHYL-BENZENEETHANAMIDE (SEE ALSO DL-AMPHETAMINE SULFATE)
alpha-Methylbenzeneethanamine
alpha-Methylbenzeneethaneamine
alpha-Methylphenethylamine
alpha-Methylphenylethylamine
Amfetamin (TN)
Amfetamina [INN-Spanish]
Amfetamina [Italian]
Amfetamine
Amfetamine (INN)
Amfetamine [INN:BAN]
amfetaminum
Amfetaminum [INN-Latin]
Amphetamin
AMPHETAMINE
AMPHETAMINE (SEE ALSO: D-AMPHETAMINE (51-64-9) & AMPHETAMINE SULFATE (60-13-9))
Amphetamine (tamper and abuse-resistant, Bio-MD/MPAR, ADHD)
Amphetamine (tamper and abuse-resistant, Bio-MD/MPAR, ADHD), PharmacoFore
Amphetamine resin complex
Amphetamine salts
Amphetamine Sulfate (2:1)
AMPHETAMINE, (D)
Amphetamine, its salts, optical isomers, and salts of its optical isomers
AN-23365
Anfetamina [Spanish]
Anorexide
Anorexine
BDBM50005246
Benzebar
Benzedrine
Benzeneethanamine, ?-methyl-, (+/-)-
Benzeneethanamine, .alpha.-methyl-
Benzeneethanamine, .alpha.-methyl-, (.+/-.)-
Benzeneethanamine, .alpha.-methyl-, (.alpha.S)-
Benzeneethanamine, .alpha.-methyl-, (S)-
Benzeneethanamine, (S)-
Benzeneethanamine, alpha-methyl-
Benzeneethanamine, alpha-methyl-, (+-)-
Benzolone
beta-Aminopropylbenzene
beta-Aminopropylbenzene (VAN)
beta-phenyl-isopropylamine
beta-Phenylisopropylamin
beta-Phenylisopropylamin [German]
beta-Phenylisopropylamine
C07514
CHEBI:132233
CHEBI:2679
CHEMBL405
component of Amodex
component of Biphetamine
d-.alpha.-Methylphenethylamine
d/l-Amphetamine hydrochloride
D/L-AMPHETAMINEHYDROCHLORIDE
D05BMG
D07445
DB00182
DEA No. 1100
Desoxynorephedrin
Desoxynorephedrine
DivK1c_000991
DL-.alpha.-Methylphenethylamine
dl-1-Phenyl-2-aminopropane
dl-alpha-Methylphenethylamine
dl-Amphetamine
DL-Amphetamine solution
DL-Amphetamine solution, 1 mg/mL in methanol, drug standard
DL-Amphetamine-d11 solution
dl-Benzedrine
DTXSID4022600
EINECS 200-458-3
EINECS 206-096-2
Elastonon
Euphodyn (Salt/Mix)
Fabedrine (Salt/Mix)
Fenamin (Salt/Mix)
Fenopromin
Fenylo-izopropylaminyl
Fenylo-izopropylaminyl [Polish]
Finam
FT-0631912
FT-0694835
GTPL4804
HMS503G03
HSDB 3287
IDI1_000991
Isoamyne
Isomyn
KB-219221
KB-50276
KBio1_000991
KWTSXDURSIMDCE-UHFFFAOYSA-N
L000864
levo-Amphetamine
LS-1148
LS-1428
MCULE-4193952437
Mecodrin
Mydrial
NINDS_000991
Noclon (Salt/Mix)
Norephedrane
Norephedrine, deoxy-
Novydrine
NSC 27159
NSC-27159
NSC-73713
NSC27159
NSC73713
NT-0201
Oktedrin
Oprea1_447423
OR038219
OR255017
Oraldrina (Salt/Mix)
Ortedrine
Ortenal (Salt/Mix)
Percomon
PF-08 (Bio-MD/MPAR/prodrug/oral, ADHD), PharmacoFore
Phenedrine
Phenethylamine, .alpha.-methyl-
Phenethylamine, .alpha.-methyl-, (.+/-.)-
Phenethylamine, (+)-
Phenethylamine, alpha-methyl-
Phenethylamine, alpha-methyl-, (+-)-
Phenethylamine, alpha-methyl, (+-)-
Phenethylamine, d-
Phenethylamine, D-.alpha.-methyl-
Profamina
Propisamine
Protioamphetamine
Psychedrine
rac-(2R)-1-phenylpropan-2-amine
rac-Amphetamine
rac-Amphetamine 1.0 mg/ml in Methanol
racemic-Desoxynor-ephedrine
Raphetamine
Rhinalator
SCHEMBL8858
Simpatedrin
Simpatina
Stimulan (Salt/Mix)
Sympametin (Salt/Mix)
Sympamine
Sympatedrine
Thyramine
Vapedrine (Salt/Mix)
Weckamine
WLN: ZY1&1R
WLN: ZY1&1R -D
Zedrine (Salt/Mix)

US Patents and Regulatory Information for DYANAVEL XR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tris Pharma Inc DYANAVEL XR amphetamine SUSPENSION, EXTENDED RELEASE;ORAL 208147-001 Oct 19, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Tris Pharma Inc DYANAVEL XR amphetamine SUSPENSION, EXTENDED RELEASE;ORAL 208147-001 Oct 19, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Tris Pharma Inc DYANAVEL XR amphetamine SUSPENSION, EXTENDED RELEASE;ORAL 208147-001 Oct 19, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Tris Pharma Inc DYANAVEL XR amphetamine SUSPENSION, EXTENDED RELEASE;ORAL 208147-001 Oct 19, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Tris Pharma Inc DYANAVEL XR amphetamine SUSPENSION, EXTENDED RELEASE;ORAL 208147-001 Oct 19, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Tris Pharma Inc DYANAVEL XR amphetamine SUSPENSION, EXTENDED RELEASE;ORAL 208147-001 Oct 19, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
McKesson
Teva
Cipla
AstraZeneca
Julphar
Moodys
Daiichi Sankyo
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.